PROCEPT BioRobotics
PRCT
17.58
-0.33
-1.84%
PROCEPT BioRobotics
US · PRCT
#3234 by market cap
Listed 2021
17.58
-0.33
-1.84%
Live - 5344 symbols - heartbeat 153s ago
· 2026-10-08 10:11
Pre-market
17.97
+0.34%
After-hours
17.91
0.00%
- Market cap
- 1.01B
- P/E (TTM)i
- -9.02
- P/Bi
- 2.96
- EPSi
- -1.72
- Div yieldi
- 0.00%
- 52W posi
- 4%
Reader sentiment
Are you bullish or bearish on PRCT?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 2 in the most recent period (2026/Q3).
- Total institutional ownership fell 0.7 percentage points.
Institutional ownership
- Held by institutions
- 98.19% -0.70pp
- Institutions
- 311 -2
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund76.95%
Hedge Fund11.98%
Public Company3.99%
Individual/Insider2.56%
Private Company1.77%
Government Pension Fund1.70%
VC/PE Fund0.79%
Insurance Company0.60%
Sovereign Wealth Fund0.28%
Top holders as of 2026-06-30
BlackRock
8.50% · 4.87M sh
T. Rowe Price Group, Inc.
8.03% · 4.60M sh
Vanguard Capital Management, LLC
5.00% · 2.86M sh
Vanguard Portfolio Management, LLC
4.41% · 2.53M sh
Chicago Capital, LLC
3.62% · 2.07M sh
State Street Global Advisors
2.82% · 1.62M sh
Geode Capital Management, LLC
2.59% · 1.48M sh
FMR
2.52% · 1.44M sh
BNPP Asset Management Holding
2.50% · 1.43M sh
Wellington Management Group
2.22% · 1.27M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 34 buys · 11 sells
| Name | Role | Stake |
|---|---|---|
| Frederic Moll | Independent Chairperson | 1.51% |
| Barry Templin | Senior Vice President of Medical Affairs & Market Access | 0.26% |
| Taylor Harris | Independent Director | 0.23% |
| Kevin Waters | Chief Financial Officer | 0.14% |
| Reza Zadno | Chief Executive Officer | 0.12% |
| Antal Desai | Independent Director | 0.09% |
| Alaleh Nouri | EVP, Chief Legal Officer & Corporate Secretary | 0.07% |
| Larry Wood | Independent Director | 0.05% |
| Hisham Shiblaq | Executive Vice President | 0.03% |
| Mary Garrett | Independent Director | 0.03% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-10-01 | Michael Mack | Independent Director | Other Acquisition | +7,727 | -- |
| 2026-10-01 | Michael Mack | Independent Director | Other Derivative Acquisition | +12,191 | $17.16 |
| 2026-09-08 | Alaleh Nouri | EVP, Chief Legal Officer & Corporate Secretary | Open Market Disposition | -297 | $20.95 |
| 2026-09-08 | Barry Templin | Senior Vice President of Medical Affairs & Market Access | Open Market Disposition | -373 | $20.95 |
| 2026-09-08 | Kevin Waters | Chief Financial Officer | Open Market Disposition | -373 | $20.95 |
| 2026-08-12 | Alaleh Nouri | EVP, Chief Legal Officer & Corporate Secretary | Other Acquisition | +22,965 | -- |
| 2026-08-12 | Alaleh Nouri | EVP, Chief Legal Officer & Corporate Secretary | Other Derivative Acquisition | +31,773 | $21.95 |
| 2026-08-12 | Barry Templin | Senior Vice President of Medical Affairs & Market Access | Other Acquisition | +26,246 | -- |
| 2026-08-12 | Barry Templin | Senior Vice President of Medical Affairs & Market Access | Other Derivative Acquisition | +36,312 | $21.95 |
| 2026-08-12 | Kevin Waters | Chief Financial Officer | Other Acquisition | +29,527 | -- |
| 2026-08-12 | Kevin Waters | Chief Financial Officer | Other Derivative Acquisition | +40,851 | $21.95 |
| 2026-08-12 | Pooja Sharma | -- | Other Acquisition | +23,622 | -- |
| 2026-08-12 | Pooja Sharma | -- | Other Derivative Acquisition | +32,681 | $21.95 |
| 2026-08-06 | Larry Wood | Independent Director | Open Market Acquisition | +23,900 | $20.85 |
| 2026-06-08 | Thomas Prescott | Chairperson of the Board | Other Acquisition | +3,315 | -- |
| 2026-06-08 | Thomas Prescott | Chairperson of the Board | Other Derivative Acquisition | +5,853 | $28.78 |
| 2026-06-08 | Frederic Moll | Independent Chairperson | Other Acquisition | +3,315 | -- |
| 2026-06-08 | Frederic Moll | Independent Chairperson | Other Derivative Acquisition | +5,853 | $28.78 |
| 2026-06-08 | Taylor Harris | Independent Director | Other Acquisition | +3,315 | -- |
| 2026-06-08 | Taylor Harris | Independent Director | Other Derivative Acquisition | +5,853 | $28.78 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 10:11:34 · For reference only, not investment advice and not tailored to your situation.